Effect of the amisulpride isomers on rat prolactinemia

Eur J Pharmacol. 2002 Jul 19;448(2-3):263-6. doi: 10.1016/s0014-2999(02)01990-8.

Abstract

The effects on rat serum prolactin level of the two isomers constituting the racemic form of amisulpride were compared. (S-)-amisulpride induced hyperprolactinemia at lower doses (ED(50) = 0.09 +/- 0.01 mg/kg) than racemic- (ED(50) = 0.24 +/- 0.03 mg/kg) and (R+)-amisulpride (ED(50) = 4.13 +/- 0.05 mg/kg), in accord with their affinities for pituitary dopamine D(2) receptor (K(i) = 3.8 +/- 0.2, 6.4 +/- 0.2 and 143.3 +/- 2.3 nM, respectively). At doses twice the ED(50), (S-)-amisulpride produced a maximal increase in prolactin level similar to that of the racemic form (403 +/- 21% and 425 +/- 15%, respectively), but higher than that of (R+)-amisulpride (198 +/- 8%). These results suggest that the hyperprolactinemia induced by the racemic-amisulpride is mostly due to its (S-)-isomer.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amisulpride
  • Animals
  • Dose-Response Relationship, Drug
  • Hyperprolactinemia / blood
  • Hyperprolactinemia / chemically induced
  • Male
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism
  • Prolactin / blood*
  • Rats
  • Rats, Sprague-Dawley
  • Stereoisomerism
  • Sulpiride / analogs & derivatives*
  • Sulpiride / chemistry*
  • Sulpiride / pharmacology*

Substances

  • Sulpiride
  • Amisulpride
  • Prolactin